Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome.

De Padua, Laura; Laurenti, Luca; Falcucci, Paolo; D'arena, Giovanni; Vannata, Barbara; Innocenti, Idanna; Autore, Francesco; Piccirillo, Nicola; Za, Tommaso; Marietti, Sara; Efremov, Dimitar G; Sica, Simona

De Padua, Laura; Laurenti, Luca; Falcucci, Paolo; D'arena, Giovanni; Vannata, Barbara; Innocenti, Idanna; Autore, Francesco; Piccirillo, Nicola; Za, Tommaso; Marietti, Sara; Efremov, Dimitar G; Sica, Simona.

Affiliation

De Padua L; Istituto di Ematologia Universita' Cattolica del Sacro Cuore, Policlinico A Gemelli, Rome, Italy.

Ann Hematol ; 93(7): 1261-2, 2014 Jul.

Article in En | MEDLINE | ID: mdl-24306088

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis; Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy; Aged; Cyclophosphamide/administration & dosage; Female; Follow-Up Studies; Humans; Male; Middle Aged; Time Factors; Treatment Outcome; Vidarabine/administration & dosage; Vidarabine/analogs & derivatives

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Antineoplastic Combined Chemotherapy Protocols Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Ann Hematol Journal subject: HEMATOLOGIA Year: 2014 Type: Article Affiliation country: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google